I

ImmunoGen Inc
XETRA:IMU

Watchlist Manager
ImmunoGen Inc
XETRA:IMU
Watchlist
Price: 8.58 EUR Market Closed
Market Cap: 1.7B EUR

Wall Street
Price Targets

IMU Price Targets Summary
ImmunoGen Inc

There are no price targets for IMU.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
ImmunoGen Inc Competitors:
Price Targets
MDXH
MDxHealth SA
111% Upside
ALNY
Alnylam Pharmaceuticals Inc
24% Upside
2480
Beijing Luzhu Biotechnology Co Ltd
34% Upside
KURA
Kura Oncology Inc
217% Upside
AMGN
Amgen Inc
1% Upside
2157
Lepu Biopharma Co Ltd
106% Upside
1801
Innovent Biologics Inc
33% Upside
BAVA
Bavarian Nordic A/S
35% Upside

Revenue
Forecast

Revenue Estimate
ImmunoGen Inc

For the last 9 years the compound annual growth rate for ImmunoGen Inc's revenue is 7%. The projected CAGR for the next 4 years is 75%.

7%
Past Growth
75%
Estimated Growth
Estimates Accuracy
10%
Average Beat

Operating Income
Forecast

Operating Income Estimate
ImmunoGen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
ImmunoGen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-53%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMU's stock price target?
Not Available

IMU doesn't have any price targets made by Wall Street professionals.

What is ImmunoGen Inc's Revenue forecast?
Projected CAGR
75%

For the last 9 years the compound annual growth rate for ImmunoGen Inc's revenue is 7%. The projected CAGR for the next 4 years is 75%.

Back to Top